Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Fish oil in recent onset rheumatoid arthritis: a randomized, double-blind controlled trial within algorithm-based drug use

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: JAMES, Michael (Royal Adelaide Hospital, Rheumatology, Adelaide, Australia)
  • Co-author(s): Proudman (Royal Adelaide Hospital, Adelaide, Australia)
    Spargo (Royal Adelaide Hospital, Adelaide, Australia)
    Metcalf (Royal Adelaide Hospital, Adelaide, Australia)
    Cleland (Royal Adelaide Hospital, Adelaide, Australia)
  • Abstract:

    Background: Randomized controlled trials (RCT) of fish oil (FO) in rheumatoid arthritis (RA) have been problematic in that (a) subjects had longstanding disease, and (b) the need to change dosing of the disease-modifying anti-rheumatic drugs (DMARDs) was usually a withdrawal criterion. We have addressed these problems in a double-blind RCT of FO..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses